ALT
Altimmune Appoints Vipin K. Garg, Ph.D. as President and Chief Executive Officer
Tuesday, November 27, 2018 BiopharmaWatch Research 1 min read Key Takeaway: Altimmune Appoints Vipin K. Garg, Ph.D. as President and Chief Executive Officer
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+22%
120-day peak, hindsight
Typical move
10.2%
average across 8 past catalysts
Cash runway
~64 mo
Minimal dilution risk
Lead asset
ALT-801
Phase 2 · Obesity/Overweight
Full Press Release Details
Altimmune Appoints Vipin K. Garg, Ph.D. as President and Chief Executive Officer.